Lataa...
Redirecting the Immune Microenvironment in Acute Myeloid Leukemia
SIMPLE SUMMARY: Despite remarkable progress in the outcome of childhood acute myeloid leukemia (AML), risk of relapse and refractory diseases remains high. Treatment of the chemo-refractory disease is restricted by dose-limiting therapy-related toxicities which necessitate alternative tolerable effi...
Tallennettuna:
| Julkaisussa: | Cancers (Basel) |
|---|---|
| Päätekijät: | , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
MDPI
2021
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8003817/ https://ncbi.nlm.nih.gov/pubmed/33804676 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13061423 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|